LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Zentalis Pharmaceuticals (NASDAQ: ZNTL)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ZNTL Zentalis Pharmaceuticals
Bruns Ingmar / officer: Chief Medical Officer
12/02/2024
Buy
$3.66
712,650
$2.608M
712,650
NASDAQ ZNTL Zentalis Pharmaceuticals
EASTLAND JULIA MARIE / director, officer: CEO & President
12/02/2024
Buy
$3.66
3.03M
$11.085M
3.03M

COPYRIGHT ©2023 HEALTH STOCKS HUB